- Current report filing (8-K)
June 22 2010 - 1:49PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 8-K
Current Report
Pursuant to Section 13 or 15(d) of
the Securities Act of 1934
Date of Report (Date of earliest event reported): June 22, 2010
Omega Protein Corporation
(Exact name of registrant as specified in its charter)
|
|
|
|
|
Nevada
|
|
001-14003
|
|
76-0562134
|
(State or other jurisdiction
of incorporation)
|
|
(Commission
File Number)
|
|
(I.R.S. Employer
Identification No.)
|
|
|
|
2105 City West Boulevard
Suite 500
Houston, Texas
|
|
77042
|
(Address of principal executive offices)
|
|
(Zip Code)
|
(713)
623-0060
(Registrants telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions (see General Instruction A.2. below):
¨
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
¨
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
¨
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14-2(b))
|
¨
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CRF 240.133-4(c))
|
Item 7.01
|
Regulation FD Disclosure
|
The Company
makes and may continue to make presentations to investors, potential investors, analysts and other groups and may utilize presentation material about the Company and its industry. The Company is filing herewith a copy of this presentation material
as Exhibit 99.1.
In accordance with General Instructions B.2 and B.6 of Form 8-K, the foregoing information, including Exhibit 99.1, shall
not be deemed filed for the purposes of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section, nor shall such information and Exhibit be deemed incorporated by reference in any
filing under the Securities Act of 1933 or the Securities Exchange Act of 1934, except as shall be expressly set forth by specific reference in such a filing.
Item 9.01
|
Financial Statements and Exhibits
|
(a)
|
Financial Statements of Businesses Acquired
|
None.
(b)
|
Pro Forma
Financial Information
|
None.
(c)
|
Shell Company Transactions
|
None.
|
99.1
|
Omega Protein Corporation June 2010 Presentation
|
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its
behalf by the undersigned thereunto duly authorized.
|
|
|
|
|
|
|
|
|
Omega Protein Corporation
|
|
|
|
Dated: June 22, 2010
|
|
|
|
/
S
/ J
OHN
D.
H
ELD
|
|
|
|
|
John D. Held
|
|
|
|
|
Executive Vice President, General Counsel and Secretary
|
Omega Protein (NYSE:OME)
Historical Stock Chart
From Aug 2024 to Sep 2024
Omega Protein (NYSE:OME)
Historical Stock Chart
From Sep 2023 to Sep 2024